Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading ...
Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $3.82 per share in its upcoming release, pointing to a year-over-year decline of 32%.
Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...
For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.
Elevance Health topped profit and revenue expectations ... Last quarter, Elevance and several competitors fell short of Wall Street's earnings estimates as costs climbed. Elevance's fourth-quarter ...
Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded ...
Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a ...
The recent price dip presents an exceptional buying opportunity, with Wall Street also bullish, averaging a price target of $500.87, a 30% upside. I am updating my analysis on Elevance Health ...
The primary driver behind last 12 months revenue was the Health Benefits segment contributing a total revenue of US$150.3b (85% of total revenue). Notably, cost of sales worth US$127.6b amounted to 72 ...
Shares of Elevance Health (NYSE:ELV) fell 12% Thursday morning ... On Tuesday, industry bellwether UnitedHealth (UNH) beat ...
Elevance Health, Inc. (NYSE:ELV – Get Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $390.50, but opened at $379.00. Elevance Health ...
UnitedHealth is under investigation by the Justice Department over its Medicare billing practices and how it records ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results